JP2008519067A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008519067A5 JP2008519067A5 JP2007540251A JP2007540251A JP2008519067A5 JP 2008519067 A5 JP2008519067 A5 JP 2008519067A5 JP 2007540251 A JP2007540251 A JP 2007540251A JP 2007540251 A JP2007540251 A JP 2007540251A JP 2008519067 A5 JP2008519067 A5 JP 2008519067A5
- Authority
- JP
- Japan
- Prior art keywords
- another example
- studies
- conducted
- producing
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- UAJUXJSXCLUTNU-UHFFFAOYSA-N Pranlukast Chemical compound C=1C=C(OCCCCC=2C=CC=CC=2)C=CC=1C(=O)NC(C=1)=CC=C(C(C=2)=O)C=1OC=2C=1N=NNN=1 UAJUXJSXCLUTNU-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001562 benzopyrans Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960004583 pranlukast Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2004-0089455 | 2004-11-04 | ||
| KR1020040089455A KR101086254B1 (ko) | 2004-11-04 | 2004-11-04 | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 |
| PCT/KR2005/003686 WO2006049433A1 (en) | 2004-11-04 | 2005-11-03 | Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008519067A JP2008519067A (ja) | 2008-06-05 |
| JP2008519067A5 true JP2008519067A5 (zh) | 2008-12-04 |
| JP5232472B2 JP5232472B2 (ja) | 2013-07-10 |
Family
ID=36319405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007540251A Expired - Fee Related JP5232472B2 (ja) | 2004-11-04 | 2005-11-03 | 向上された生体利用効率を備えるプランルカスト固体分散体組成物およびその固体分散体の製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP5232472B2 (zh) |
| KR (1) | KR101086254B1 (zh) |
| AR (1) | AR051758A1 (zh) |
| MX (1) | MX2007005427A (zh) |
| TW (1) | TWI380829B (zh) |
| WO (1) | WO2006049433A1 (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101233235B1 (ko) * | 2005-08-26 | 2013-02-15 | 에스케이케미칼주식회사 | 초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법 |
| CN101835492B (zh) | 2007-08-21 | 2012-11-21 | 德克萨斯州立大学董事会 | 用于制药应用的热动力学混合 |
| EP4008314A3 (en) * | 2007-08-21 | 2022-11-09 | Board of Regents, The University of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
| EP2140861A1 (en) * | 2008-06-30 | 2010-01-06 | Abbott GmbH & Co. KG | Pharmaceutical dosage form comprising polymeric carrier composition |
| GB201103837D0 (en) * | 2011-03-07 | 2011-04-20 | Oxagen Ltd | Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid |
| KR101381881B1 (ko) * | 2012-03-12 | 2014-04-04 | 충남대학교산학협력단 | 용해도 및 용출율이 개선된 프란루카스트 나노 고체 분산체의 제조방법 |
| KR101446129B1 (ko) * | 2012-10-10 | 2014-10-06 | 조선대학교산학협력단 | 프란루카스트-함유 고형 제제의 제조방법 |
| KR102191562B1 (ko) * | 2012-11-07 | 2020-12-15 | 에스케이바이오팜 주식회사 | 난용성 약물의 고체분산체 및 이의 제조방법 |
| KR102363727B1 (ko) | 2015-06-01 | 2022-02-16 | 삼아제약 주식회사 | 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법 |
| WO2020012498A1 (en) | 2018-07-13 | 2020-01-16 | Council Of Scientific & Industrial Research | Solid dispersion comprising an anticancer compound with improved solubility and efficacy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19509807A1 (de) * | 1995-03-21 | 1996-09-26 | Basf Ag | Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen |
| EP0834314B1 (en) * | 1995-06-12 | 2003-01-15 | Ono Pharmaceutical Co., Ltd. | Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast |
| US5858509A (en) * | 1996-11-15 | 1999-01-12 | Digital Equipment Corporation | Attenuating vibrations in a mounting shelf for multiple disk drives |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| KR100381834B1 (ko) * | 2000-05-20 | 2003-04-26 | 이상득 | 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법 |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
-
2004
- 2004-11-04 KR KR1020040089455A patent/KR101086254B1/ko active IP Right Grant
-
2005
- 2005-11-03 WO PCT/KR2005/003686 patent/WO2006049433A1/en active Application Filing
- 2005-11-03 AR ARP050104618A patent/AR051758A1/es unknown
- 2005-11-03 MX MX2007005427A patent/MX2007005427A/es not_active Application Discontinuation
- 2005-11-03 JP JP2007540251A patent/JP5232472B2/ja not_active Expired - Fee Related
- 2005-11-04 TW TW094138786A patent/TWI380829B/zh not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008519067A5 (zh) | ||
| JP2008506632A5 (zh) | ||
| IL191711A0 (en) | 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors | |
| EP1740156B8 (de) | Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform | |
| JP2009545657A5 (zh) | ||
| JP2009541403A5 (zh) | ||
| IL218714A0 (en) | Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof | |
| ATE531717T1 (de) | Neue kristalline form eines pyridazinoä4,5- büindolderivats | |
| IL183568A (en) | Process for making 7,8-dihydro-5 h-patridine-6-onh | |
| WO2007067890A3 (en) | Method of dust abatement | |
| EP1770085A4 (en) | DIAMINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND FUNGICIDE CONTAINING THE DERIVATIVE AS ACTIVE INGREDIENT | |
| JP2004161535A5 (zh) | ||
| TWI348593B (en) | Amine compound, chemically amplified resist composition and patterning process | |
| JP2009538861A5 (zh) | ||
| WO2006081515A3 (en) | Duloxetine hydrochloride polymorphs | |
| WO2006123243A3 (en) | Pharmaceutical dosage forms comprising escitalopram in form of granules | |
| SG170081A1 (en) | Method of patterning and product(s) obtained therefrom | |
| JP2010535829A5 (zh) | ||
| WO2008065051A3 (de) | Herstellung von festen lösungen von pestiziden durch kurzzeitüberhitzung und schnelle trocknung | |
| JP2008104450A5 (zh) | ||
| EP1934170A4 (en) | NEW IMINCALIXARINE DERIVATIVES AND AMINOCALIXAR DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND SELF ASSOCIATED MONOGRAPH MAKED BY THE PROCESS, METHOD FOR IMMOBILIZING OLIGO DNA USING THE SELF-ASSOCIATED MONOGRAPH AND OLIGO DNA CHIP PRODUCED BY THIS PROCESS | |
| JP2006519093A5 (zh) | ||
| WO2008074693A3 (en) | Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone | |
| WO2007039076A3 (en) | Niobium compound | |
| FR2842524B1 (fr) | Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments |